Therapeutic Alpha-Interferons Protein: Structure, Production, and Biosimilar

By El-Baky Nawal Abd   Redwan Elrashdy M.  

Preparative Biochemistry & Biotechnology, Vol. 45, Iss. 2, 2015-02 ,pp. : 109-127

Taylor & Francis Ltd

Access to resources Recommend Favorite

Enzymatic and hyperglycemia stability of chemically modified insulins with hydrophobic acyl groups

By Nakashima K.   Miyagi M.   Goto K.   Matsumoto Y.   Ueoka R.  

Bioorganic and Medicinal Chemistry Letters, Vol. 14, Iss. 2, 2004-01 ,pp. : 481-483

Elsevier

Access to resources Recommend Favorite

The development of new basal insulins: is there any clinical advantage with their use in type 2 diabetes?

By Maiorino Maria Ida   Petrizzo Michela   Capuano Annalisa   Giugliano Dario   Esposito Katherine  

Expert Opinion on Biological Therapy, Vol. 14, Iss. 6, 2014-06 ,pp. : 799-808

Informa Healthcare

Access to resources Recommend Favorite

Contrasting toxicokinetic evaluations and interspecies pharmacokinetic scaling approaches for small molecules and biologics: applicability to biosimilar development

By Offman Elliot   Edginton Andrea N.  

Xenobiotica, Vol. 43, Iss. 6, 2013-06 ,pp. : 561-569

Informa Healthcare

Access to resources Recommend Favorite